•   +1 646 480 7505 (US)

Viral Vaccine Market Size, Share & Trends Analysis Report By Type (Attenuated Vaccine, Inactivated Vaccine), By Application (Adults, Children), By Region, And Segment Forecasts, 2023 – 2031


Choose License Type

Table Of Content

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: Viral Vaccine Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on Viral Vaccine Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. Viral Vaccine Market, Segment by Type
    1. Introduction
      1. Market Size and Forecast, Segment by Type
    2. Attenuated Vaccine
      1. Market Size and Forecast, By Region
    3. Inactivated Vaccine
      1. Market Size and Forecast, By Region
  10. Viral Vaccine Market, Segment by Application
    1. Introduction
      1. Market Size and Forecast, Segment by Application
    2. Adults
      1. Market Size and Forecast, By Region
    3. Children
      1. Market Size and Forecast, By Region
  11. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. North America
      1. Market Size and Forecast
        1. Segment by Type
          1. Attenuated Vaccine
            1. Inactivated Vaccine
            2. Segment by Application
              1. Adults
                1. Children
              2. U.S.
                1. Segment by Type
                  1. Attenuated Vaccine
                    1. Inactivated Vaccine
                    2. Segment by Application
                      1. Adults
                        1. Children
                      2. Canada
                    3. Europe
                      1. Market Size and Forecast
                        1. Segment by Type
                          1. Attenuated Vaccine
                            1. Inactivated Vaccine
                            2. Segment by Application
                              1. Adults
                                1. Children
                              2. U.K.
                                1. Segment by Type
                                  1. Attenuated Vaccine
                                    1. Inactivated Vaccine
                                    2. Segment by Application
                                      1. Adults
                                        1. Children
                                      2. Germany
                                      3. France
                                      4. Spain
                                      5. Italy
                                      6. Russia
                                      7. Nordic
                                      8. Benelux
                                      9. Rest of Europe
                                    3. APAC
                                      1. Market Size and Forecast
                                        1. Segment by Type
                                          1. Attenuated Vaccine
                                            1. Inactivated Vaccine
                                            2. Segment by Application
                                              1. Adults
                                                1. Children
                                              2. China
                                                1. Segment by Type
                                                  1. Attenuated Vaccine
                                                    1. Inactivated Vaccine
                                                    2. Segment by Application
                                                      1. Adults
                                                        1. Children
                                                      2. Korea
                                                      3. Japan
                                                      4. India
                                                      5. Australia
                                                      6. Singapore
                                                      7. Taiwan
                                                      8. South East Asia
                                                      9. Rest of Asia-Pacific
                                                    3. Middle East and Africa
                                                      1. Market Size and Forecast
                                                        1. Segment by Type
                                                          1. Attenuated Vaccine
                                                            1. Inactivated Vaccine
                                                            2. Segment by Application
                                                              1. Adults
                                                                1. Children
                                                              2. UAE
                                                                1. Segment by Type
                                                                  1. Attenuated Vaccine
                                                                    1. Inactivated Vaccine
                                                                    2. Segment by Application
                                                                      1. Adults
                                                                        1. Children
                                                                      2. Turky
                                                                      3. Saudi Arabia
                                                                      4. South Africa
                                                                      5. Egypt
                                                                      6. Nigeria
                                                                      7. Rest of MEA
                                                                    3. LATAM
                                                                      1. Market Size and Forecast
                                                                        1. Segment by Type
                                                                          1. Attenuated Vaccine
                                                                            1. Inactivated Vaccine
                                                                            2. Segment by Application
                                                                              1. Adults
                                                                                1. Children
                                                                              2. Brazil
                                                                                1. Segment by Type
                                                                                  1. Attenuated Vaccine
                                                                                    1. Inactivated Vaccine
                                                                                    2. Segment by Application
                                                                                      1. Adults
                                                                                        1. Children
                                                                                      2. Mexico
                                                                                      3. Argentina
                                                                                      4. Chile
                                                                                      5. Colombia
                                                                                      6. Rest of LATAM
                                                                                  2. Competitive Landscape, 2023
                                                                                    1. Introduction
                                                                                    2. Viral Vaccine Market Share Analysis, 2023 (%)
                                                                                      1. Market Share Analysis, 2023
                                                                                      2. Competition Ranking, 2023
                                                                                      3. Key Developments & Growth Strategies
                                                                                        1. Merger & Acquisition
                                                                                        2. Product Launch
                                                                                        3. Expansion
                                                                                      4. Consolidated SWOT Analysis of Key Players
                                                                                  3. Company Profile
                                                                                    1. GSK
                                                                                      1. Business Overview
                                                                                      2. Financial Data
                                                                                      3. Key Product Categories
                                                                                      4. Recent Developments
                                                                                    2. Merck
                                                                                    3. Novartis
                                                                                    4. Pfizer
                                                                                    5. Sanofi Pasteur
                                                                                    6. Bayer
                                                                                    7. Zoetis
                                                                                    8. AstraZeneca
                                                                                    9. Johnson & Johnson
                                                                                    10. CSL Limited
                                                                                    11. Astellas Pharma
                                                                                    12. Emergent BioSolutions
                                                                                    13. MedImmune
                                                                                    14. Serum Institute of India
                                                                                    15. Encephalitis 
                                                                                    16. Cochrane Collaboration
                                                                                    17. Sonic HealthPlus
                                                                                    18. Superdrug Health
                                                                                    19. CNBG
                                                                                    20. Changsheng Life
                                                                                    21. Baxter
                                                                                    22. ChengDa Bio
                                                                                    23. Boehringer Ingelheim
                                                                                    24. SINOVAC BIOTECH
                                                                                    25. Hissen
                                                                                    26. Walvax Biotechnology
                                                                                    27. Rong An
                                                                                    28. NuoCheng Bio
                                                                                    29. Hualan Bio
                                                                                    30. Tiantan Biological

                                                                                  	

                                                                                  Choose License Type

                                                                                  Testimonials

                                                                                  Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
                                                                                  VP of a Automotive division in Germany

                                                                                  The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
                                                                                  Product Manager at US based Manufacturer

                                                                                  Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
                                                                                  Marketing Manager at a pharma company in Belgium

                                                                                  Our Clients

                                                                                  Accenture
                                                                                  bcg
                                                                                  arthurd
                                                                                  cater
                                                                                  dupont
                                                                                  henergy
                                                                                  inter paper
                                                                                  lanxess
                                                                                  l university
                                                                                  marsall
                                                                                  medowfood
                                                                                  nsk
                                                                                  oldworld
                                                                                  qualcomm
                                                                                  samsung